Suspicious Order Monitoring Analytics and Reports
Suspicious Order Monitoring (SOMS)
Analytics and Reporting Overview
Traditionally, the pharmaceutical industry has monitored purchase orders for unusual sizes and patterns. Manufacturers should continue this practice as part of compliance and risk monitoring. However, there are notable gaps when exclusively relying on the traditional approach.
A comprehensive solution must also monitor and potentially report whether individual pharmacies are over procuring Schedule 2 drugs. Enriched 867 data provides complete visibility to all ordering at the individual ship-to location level across wholesalers and distributors.
New Approach Using Enriched 867 Data
In addition to capturing the size and frequency of orders, IntegriChain can enhance the accuracy of monitoring and reporting suspicious orders at the pharmacy by including the following metrics:
- Zip-code level per capita dispensing
- National per capita dispensing
- Pharmacy decile (Overall Rx dispensing)
- Product decile (Brand Rx dispensing)
- Market decile (Market level Rx dispensing)
- Historical mix/max order at the distributor/pharmacy level
Pharmacy
- Unblinded sell-in data for all ~64K pharmacy locations
- Includes pharmacy classes of trade including 340B contract pharmacy
- Enriched deciles of each outlet by brand, market basket and overall pharmacy size
Census Demographics
- Crosswalks Pharmacy dataset at the zip-code level to population counts
- Used to determine zip-code level per capita dispensing rates by brand, market basket, and overall pharmacy
Red Flag Pharmacies
- Identify pharmacies that have high levels of product purchasing
- Trace high orders to originating distributor